Dendritic cell vaccination and immune monitoring

被引：0
作者：
E. H. J. G. Aarntzen
C. G. Figdor
G. J. Adema
C. J. A. Punt
I. J. M. de Vries
机构：
[1] Nijmegen Centre for Molecular Life Sciences,Department of Medical Oncology
[2] Radboud University Nijmegen Medical Centre,Department of Tumor Immunology
[3] Nijmegen Centre for Molecular Life Sciences,Department of Pediatric Hemato
[4] Radboud University Nijmegen Medical Centre,Oncology
[5] Nijmegen Centre for Molecular Life Sciences,undefined
[6] Radboud University Nijmegen Medical Centre,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Dendritic cells; Specific immune responses; Migration; mRNA transfection; In vivo targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We exploited dendritic cells (DC) to vaccinate melanoma patients. We recently demonstrated a statistical significant correlation between favorable clinical outcome and the presence of vaccine-related tumor antigen-specific T cells in delayed type hypersensitivity (DTH) skin biopsies. However, favorable clinical outcome is only observed in a minority of the treated patients. Therefore, it is obvious that current DC-based protocols need to be improved. For this reason, we study in small proof of principle trials the fate, interactions and effectiveness of the injected DC.
引用
收藏
页码：1559 / 1568
页数：9
相关论文
共 50 条
  • [31] Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination
    Laverman, P
    de Vries, IJM
    Scharenborg, NM
    de Boer, A
    Broekema, M
    Oyen, WJG
    Figdor, CG
    Adema, GJ
    Boerman, OC
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (04) : 453 - 458
  • [32] In situ dendritic cell vaccination for the treatment of glioma and literature review
    Li, Ming
    Han, Shuangyin
    Shi, Xiwen
    TUMOR BIOLOGY, 2016, 37 (02) : 1797 - 1801
  • [33] Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
    Papewalis, C.
    Wuttke, M.
    Jacobs, B.
    Domberg, J.
    Willenberg, H.
    Baehring, T.
    Cupisti, K.
    Raffel, A.
    Chao, L.
    Fenk, R.
    Seissler, J.
    Scherbaum, W. A.
    Schott, M.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (02) : 108 - 116
  • [34] Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells
    Zarei, S
    Arrighi, JF
    Ongaro, G
    Calzascia, T
    Haller, O
    Frossard, C
    Piguet, V
    Walker, PK
    Hauser, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (04) : 745 - 750
  • [35] Programmed cell death of dendritic cells in immune regulation
    Chen, Min
    Wang, Jin
    IMMUNOLOGICAL REVIEWS, 2010, 236 : 11 - 27
  • [36] Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy
    Xiang, Jian
    Xu, Ligeng
    Gong, Hua
    Zhu, Wenwen
    Wang, Chao
    Xu, Jun
    Feng, Liangzhu
    Cheng, Liang
    Peng, Rui
    Liu, Zhuang
    ACS NANO, 2015, 9 (06) : 6401 - 6411
  • [37] Dendritic Cell Immune Therapy to Break or Induce Tolerance
    Amodio G.
    Annoni A.
    Gregori S.
    Current Stem Cell Reports, 2015, 1 (4) : 197 - 205
  • [38] Changes in dendritic cell function in the immune response to sepsis
    Huang, Xin
    Venet, Fabienne
    Chung, Chun-Shiang
    Lomas-Neira, Joanne
    Ayala, Alfred
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (07) : 929 - 938
  • [39] Matrix-Bound Hyaluronan Molecular Weight as a Regulator of Dendritic Cell Immune Potency
    Quartey, Brian Chesney
    Sapudom, Jiranuwat
    Elgindi, Mei
    Alatoom, Aseel
    Teo, Jeremy
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (08)
  • [40] Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
    Nicolai Leonhartsberger
    Reinhold Ramoner
    Claudia Falkensammer
    Andrea Rahm
    Hubert Gander
    Lorenz Höltl
    Martin Thurnher
    Cancer Immunology, Immunotherapy, 2012, 61 : 1407 - 1413
12345